Back to methods browser

First-pass extracted concept

PIONEER

Candidate: toolkit itemType: assay method1 source documents6 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

Periplasmic dIsplay Of geNetically Encoded rEgulatoRs

Extracted Explainers

What the tool is doing

PIONEER is a modular yeast periplasmic display platform that localizes peptides, proteins, and nanobodies near the membrane to interrogate target function. The abstract emphasizes functional signaling readout rather than binding-only assessment.

Source 1DOIPubMed

Resources required

The platform requires a Saccharomyces cerevisiae display system, secretion-signal and scaffold optimization, and an autocrine signaling-compatible assay context. Demonstrated use is with human GPCRs.

Source 1DOIPubMed

What problem it solves

It addresses the need to connect genetically encoded candidate ligands or binders to biological function in a scalable screen. The platform is presented as especially useful as AI design expands candidate sequence space.

Source 1DOIPubMed

What it does not solve

The abstract does not show that PIONEER solves all target classes equally well, and its explicit demonstrations are focused on GPCRs. It also does not claim to replace all downstream validation beyond yeast functional screening.

Source 1DOIPubMed

Alternatives

The abstract contrasts PIONEER with approaches that assess binding alone rather than signaling. The web summary also identifies DCyFIR as an upstream related platform, but the abstract itself does not detail a direct head-to-head comparison.

Source 1DOIPubMed

Evidence Snippets

We present Periplasmic dIsplay Of geNetically Encoded rEgulatoRs (PIONEER), a modular platform that localizes peptides, proteins, and nanobodies to the membrane-proximal periplasmic space of Saccharomyces cerevisiae, enabling direct interrogation of membrane protein function.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1adaptabilitysupports2026Source 1DOIPubMed

Although demonstrated with GPCRs, PIONEER is described as adaptable to a wide range of membrane and soluble protein targets.

Quoted textsource-backed
Although demonstrated with G protein-coupled receptors, PIONEER is adaptable to a wide range of membrane and soluble protein targets.
Claim 2application scopesupports2026Source 1DOIPubMed

PIONEER distinguishes intrabodies based on their functional effects and chaperone activity.

Quoted textsource-backed
It also distinguishes intrabodies based on their functional effects and chaperone activity.
Claim 3application scopesupports2026Source 1DOIPubMed

When applied to human GPCRs, PIONEER enables detection of surface expression, ligand activity profiling, and classification of nanobody regulators including antagonists and conformational stabilizers.

Quoted textsource-backed
Applied to human G protein-coupled receptors, the system enables detection of surface expression, ligand activity profiling, and classification of nanobody regulators, including antagonists and conformational stabilizers.
Claim 4engineering optimizationsupports2026Source 1DOIPubMed

Optimization of secretion signals and display scaffolds in PIONEER supports stable ligand retention and robust autocrine signaling.

Quoted textsource-backed
By optimizing secretion signals (ss) and display scaffolds, PIONEER ensures stable ligand retention and robust autocrine signaling.
Claim 5platform capabilitysupports2026Source 1DOIPubMed

PIONEER localizes peptides, proteins, and nanobodies to the membrane-proximal periplasmic space of Saccharomyces cerevisiae to enable direct interrogation of membrane protein function.

Quoted textsource-backed
We present Periplasmic dIsplay Of geNetically Encoded rEgulatoRs (PIONEER), a modular platform that localizes peptides, proteins, and nanobodies to the membrane-proximal periplasmic space of Saccharomycescerevisiae, enabling direct interrogation of membrane protein function.
Claim 6screening modesupports2026Source 1DOIPubMed

PIONEER enables function-first screening by assessing peptide and protein ligand activity through signaling rather than binding alone.

Quoted textsource-backed
The ability to assess peptide and protein ligand activity through signaling, rather than binding alone, marks a key advance toward function-first screening.